Multiple endocrine neoplasia: the Chilean experience

Area of Science:

• Endocrinology
• Genetics
• Oncology

Background:

• Multiple endocrine neoplasia (MEN) types 1 and 2 are autosomal genetic disorders.
• MEN type 1 involves parathyroid, pituitary, and pancreatic tumors.
• MEN type 2 is characterized by medullary thyroid carcinoma and pheochromocytoma.

Purpose of the Study:

• To evaluate the role of genetic testing in diagnosing and managing MEN types 1 and 2.
• To highlight the benefits of early detection and prophylactic interventions.

Main Methods:

• Review of genetic testing protocols for MEN1 and MEN2.
• Analysis of genotype-phenotype correlations in MEN1.
• Description of prophylactic thyroidectomy in a pediatric patient with MEN2.
• Comparison of biochemical cure rates between genetically diagnosed and clinically diagnosed patients.

Main Results:

• Genetic testing for MEN1 is most advantageous for excluding individuals without the mutation in affected families.
• Prophylactic thyroidectomy in a 3-year-old with MEN2 prevented advanced disease.
• Biochemical cure rates were over 90% for genetically diagnosed patients versus 27% for clinically diagnosed patients.
• Common MEN2 mutations include C634W in exon 11; C634R is less frequent.

Conclusions:

• Genetic testing and early diagnosis, particularly for medullary thyroid carcinoma and pheochromocytoma, are crucial for improving survival in MEN patients.
• Timely intervention significantly enhances treatment outcomes compared to clinical diagnosis alone.